Page last updated: 2024-08-25

voriconazole and Lymphohistiocytosis, Hemophagocytic

voriconazole has been researched along with Lymphohistiocytosis, Hemophagocytic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aleshin, M; Borok, J; Sarantopoulos, G; Worswick, S1
Asano, M; Hasegawa, Y; Hashimoto, N; Ishigami, M; Majima, S; Okachi, S; Sato, M; Wakahara, K1

Other Studies

2 other study(ies) available for voriconazole and Lymphohistiocytosis, Hemophagocytic

ArticleYear
Image Gallery: Immunocompromised patient presenting with inguinal rash: a case of Scedosporium apiospermum.
    The British journal of dermatology, 2017, Volume: 176, Issue:4

    Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Dermatomycoses; Dexamethasone; Drug Eruptions; Etoposide; Exanthema; Humans; Immunocompromised Host; Lymphohistiocytosis, Hemophagocytic; Lymphoma, B-Cell; Male; Opportunistic Infections; Scedosporium; Voriconazole

2017
Pseudomembranous Invasive Tracheobronchial Aspergillosis with Fulminant Hepatitis and Hemophagocytic Syndrome.
    Internal medicine (Tokyo, Japan), 2018, Aug-15, Volume: 57, Issue:16

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchi; Bronchoalveolar Lavage Fluid; Female; Hepatitis; Humans; Lymphohistiocytosis, Hemophagocytic; Middle Aged; Trachea; Treatment Outcome; Voriconazole

2018